FDA
-
-
-
-
-
-
-
ADC Therapeutics cuts 17% of workforce, targets $10M in savings
-
-
-
-
-
-
-
ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026
-
-
-
-
-
-
-
ADC Therapeutics amends financing deal, reducing change of control payment
-
-
-
-
-
-
-
ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/
-
-
-
-
-
-
-
ADC Therapeutics Announces $60 Million Private Placement
-
-
-
-
-
-
-
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
-
-
-
-
-
-
-
ADC Therapeutics SA (ADCT) Announces Updated Data from LOTIS-7 Clinical Trial
-
329,009 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

